Document Detail

Component-resolved diagnosis of wasp (yellow jacket) venom allergy.
MedLine Citation:
PMID:  23331567     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Wasp venom allergy is a potentially life-threatening condition with serious consequences of diagnostic error.
OBJECTIVE: To assess whether component-resolved diagnosis, using non-glycosylated recombinant allergen components from yellow jacket can add to the diagnosis of wasp venom allergy.
METHODS: In total, 148 patients with a wasp (yellow jacket) allergy were included, 91 with unequivocal tests, 26 with double positivity of serum-specific IgE (sIgE) to both venoms, 21 with discrepant sIgE and skin test results and finally 10 having their diagnosis only confirmed by basophil activation test (negative sIgE and skin test results). Specific IgE to recombinant species-specific allergen components Ves v 1 and Ves v 5 from yellow jacket, Api m 1 from honeybee and Ves v 5 complemented wasp venom were tested by ImmunoCAP.
RESULTS: Overall, combined use of sIgE to rVes v 1 and rVes v 5 allowed correct diagnosis in 139 of the 148 patients (94%) and rApi m 1 was demonstrable in only one patient. Supplementing the traditional yellow jacket allergosorbent with rVes v 5 allowed to correctly diagnose wasp allergy in patients sensitized to Ves v 5 but demonstrating a negative sIgE to wasp venom.
CONCLUSION: Component-resolved diagnoses with the wasp-specific recombinant allergen components Ves v 1 and Ves v 5 is a reliable method to diagnose yellow jacket allergy and can help to take out the sting of difficult cases. However, as the number of patients with doubt after conventional tests is small, larger collaborative studies are needed to draw more definitive conclusions. Whether the rVes v 5 supplemented yellow jacket allergosorbent constitutes an asset in the diagnostic management of wasp venom allergy remains to be further established.
D G Ebo; M Faber; V Sabato; J Leysen; C H Bridts; L S De Clerck
Related Documents :
17362597 - Hosts of glossina fuscipes fuscipes and g. pallidipes in areas of western kenya with en...
1750127 - Human immunodeficiency virus type 1 infection in a community of southern mozambique.
2816177 - Enzyme-linked immunosorbent assay (elisa) using staphylococcal protein a for the measur...
1429127 - Seroprevalence of antibodies to borrelia burgdorferi in a population of horses in centr...
8108717 - The regulatory problems in estimating the toxicity of wood preservatives to bats.
18714247 - Unilateral balance performance in female collegiate soccer athletes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology     Volume:  43     ISSN:  1365-2222     ISO Abbreviation:  Clin. Exp. Allergy     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8906443     Medline TA:  Clin Exp Allergy     Country:  England    
Other Details:
Languages:  eng     Pagination:  255-61     Citation Subset:  IM    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology, University of Antwerp, Antwerpen (Belgium) and Antwerp University Hospital, Antwerpen, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy.
Next Document:  Acidic amorphous silica prepared from iron oxide of bacterial origin.